Insights into the Prognostic Role of Serum Interleukin-6 and Hematobiochemical Alterations in Cattle during Recent Outbreaks of Lumpy Skin Disease in Lodhran District, Pakistan
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Area
2.2. Animal Population and Clinical Presentation
2.3. Samples Collection and Preparation
2.4. Identification of LSDV through PCR
2.5. Hematological Parameters
2.6. Biochemical Parameters and IL-6 Estimation
2.7. Statistical Analysis
3. Results
3.1. Confirmation of LSDV through PCR
3.2. Hematological Parameters
3.3. Biochemical Findings
3.4. Serum Interleukin-6 Levels
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
Lumpy skin disease | (LSD) |
Interleukin-6 | (IL-6) |
Polymerase chain reaction | (PCR) |
Lumpy skin disease virus | (LSDV) |
Receiver-operating characteristic | (ROC) |
Area under the curve | (AUC) |
Ethylene diamine tetraacetic acid | (EDTA) |
DNA | (deoxyribonucleic acid) |
RNA | (Ribonucleic acid) |
Red blood cells | (RBCs) |
Hemoglobin | (Hb) |
Packed cell volume | (PCV) |
Mean corpuscular volume | (MCV) |
Mean corpuscular hemoglobin concentration | (MCHC) |
White blood cells | (WBCs) |
Aspartate aminotransferase | (AST) |
Alkaline phosphatase | (ALP) |
Lactate dehydrogenase | (LDH) |
Creatinine phosphokinase | (CPK) |
ELISA | (Enzyme Linked Immunosorbent Assay) |
ANOVA | (Analysis of Variance) |
TLC | (Total Leukocyte Count) |
DLC | (Differential Leukocyte Count) |
CPK | (Creatinine Phosphokinase) |
TNF-α | (Tumor Necrosis Factor-alpha) |
IL-1β | (Interleukin-1 beta) |
IFN-γ | (Interferon gamma) |
Packed cell volume | (PCV) |
Confidence interval | (CI) |
Picogram per milliliter | (pg/mL) |
References
- Babiuk, S.; Bowden, T.R.; Boyle, D.B.; Wallace, D.B.; Kitching, R.P. Capripoxviruses: An emerging worldwide threat to sheep, goats and cattle. Transbound. Emerg. Dis. 2008, 55, 263–272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tuppurainen, E.S.M.; Venter, E.H.; Shisler, J.L.; Gari, G.; Mekonnen, G.A.; Juleff, N.; Lyons, N.A.; De Clercq, K.; Upton, C.; Bowden, T.R. Capripoxvirus diseases: Current status and opportunities for control. Transbound. Emerg. Dis. 2017, 64, 729–745. [Google Scholar] [CrossRef] [PubMed]
- Sharawi, S.S.A.; Abd El-Rahim, I.H.A. The utility of polymerase chain reaction for diagnosis of lumpy skin disease in cattle and water buffaloes in Egypt. Rev. Sci. Tech. 2011, 30, 821. [Google Scholar] [CrossRef] [PubMed]
- Irons, P.C.; Tuppurainen, E.S.M.; Venter, E.H. Excretion of lumpy skin disease virus in bull semen. Theriogenology 2005, 63, 1290–1297. [Google Scholar] [CrossRef]
- Leliso, S.A.; Bari, F.D.; Chibssa, T.R. Molecular Characterization of Lumpy Skin Disease Virus Isolates from Outbreak Cases in Cattle from Sawena District of Bale Zone, Oromia, Ethiopia. Vet. Med. Int. 2021, 2021. [Google Scholar] [CrossRef] [PubMed]
- Ochwo, S.; VanderWaal, K.; Ndekezi, C.; Nkamwesiga, J.; Munsey, A.; Witto, S.G.; Nantima, N.; Mayanja, F.; Okurut, A.R.A.; Atuhaire, D.K. Molecular detection and phylogenetic analysis of lumpy skin disease virus from outbreaks in Uganda 2017–2018. BMC Vet. Res. 2020, 16, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Manual, O.I.E.T. Lumpy skin disease, Chapter 2.4. OIE Paris 2010, 14. [Google Scholar]
- Sprygin, A.; Pestova, Y.; Wallace, D.B.; Tuppurainen, E.; Kononov, A.V. Transmission of lumpy skin disease virus: A short review. Virus Res. 2019, 269, 197637. [Google Scholar] [CrossRef]
- Neamat-Allah, A.N.F. Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease. Vet. World 2015, 8, 1131. [Google Scholar] [CrossRef] [Green Version]
- El-Neweshy, M.S.; El-Shemey, T.M.; Youssef, S.A. Pathologic and immunohistochemical findings of natural lumpy skin disease in Egyptian cattle. Pak. Vet. J. 2013, 33, 60–64. [Google Scholar]
- Rouby, S.R.; Safwat, N.M.; Hussein, K.H.; Abdel-Ra’ouf, A.M.; Madkour, B.S.; Abdel-Moneim, A.S.; Hosein, H.I. Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings. PLoS ONE 2021, 16, e0258755. [Google Scholar] [CrossRef]
- Sadek, K.; Saleh, E.; Ayoub, M. Selective, reliable blood and milk bio-markers for diagnosing clinical and subclinical bovine mastitis. Trop. Anim. Health Prod. 2017, 49, 431–437. [Google Scholar] [CrossRef] [PubMed]
- Shakeeb, N.; Varkey, P.; Ajit, A. Human saliva as a diagnostic specimen for early detection of inflammatory biomarkers by real-time RT-PCR. Inflammation 2021, 44, 1713–1723. [Google Scholar] [CrossRef]
- Uciechowski, P.; Dempke, W.C.M. Interleukin-6: A masterplayer in the cytokine network. Oncology 2020, 98, 131–137. [Google Scholar] [CrossRef] [PubMed]
- Sbuster, D.E.; Kehrli, M.E.; Stevens, M.G. Cytokine production during endotoxin-induced mastitis in lactating dairy cows. Am. J. Vet. Res. 1993, 54, 80. [Google Scholar]
- Mukherjee, J.; Varshney, N.; Chaudhury, M.; Mohanty, A.K.; Dang, A.K. Immune response of the mammary gland during different stages of lactation cycle in high versus low yielding Karan Fries crossbred cows. Livest. Sci. 2013, 154, 215–223. [Google Scholar] [CrossRef]
- Chen, R.; Wang, H.; Zhao, Y.; Nan, X.; Wei, W.; Du, C.; Zhang, F.; Luo, Q.; Yang, L.; Xiong, B. Quantitative Detection of Mastitis Factor IL-6 in Dairy Cow Using the SERS Improved Immunofiltration Assay. Nanomaterials 2022, 12, 1091. [Google Scholar] [CrossRef] [PubMed]
- El-Mandrawy, S.A.M.; Alam, R.T.M. Hematological, biochemical and oxidative stress studies of lumpy skin disease virus infection in cattle. J. Appl. Anim. Res. 2018, 46, 1073–1077. [Google Scholar] [CrossRef] [Green Version]
- Fischer, S.; Bauerfeind, R.; Czerny, C.-P.; Neumann, S. Serum interleukin-6 as a prognostic marker in neonatal calf diarrhea. J. Dairy Sci. 2016, 99, 6563–6571. [Google Scholar] [CrossRef]
- Lamien, C.E.; Le Goff, C.; Silber, R.; Wallace, D.B.; Gulyaz, V.; Tuppurainen, E.; Madani, H.; Caufour, P.; Adam, T.; El Harrak, M. Use of the Capripoxvirus homologue of Vaccinia virus 30 kDa RNA polymerase subunit (RPO30) gene as a novel diagnostic and genotyping target: Development of a classical PCR method to differentiate Goat poxvirus from Sheep poxvirus. Vet. Microbiol. 2011, 149, 30–39. [Google Scholar] [CrossRef]
- Varadarajan, M.-T.; Karuppannan, A.K. Molecular diagnosis, phylogenetic analysis and identification of an unique SNP in the viral attachment protein (p32) gene of Lumpy skin Disease Virus in tissue biopsies of Cattle in India. Res. Sq. 2022; Preprint. [Google Scholar]
- Feldman, B.V.; Zinkl, J.G.; Jain, N.C.; Schalm, O.W. Schalm’s Veterinary Hematology; Feldman, B.V., Zinkl, J.G., Jain, N.C., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2000; ISBN 0683306928. [Google Scholar]
- Doumas, B.T.; Bayse, D.D.; Carter, R.J.; Peters Jr, T.; Schaffer, R. A candidate reference method for determination of total protein in serum. I. Development and validation. Clin. Chem. 1981, 27, 1642–1650. [Google Scholar] [CrossRef] [PubMed]
- Drupt, F. Colorimetric method for determination of albumin. Pharm. Biol 1974, 9, 777–779. [Google Scholar]
- Reinhold, J.G. Total protein, albumin, and globulin. Stand. Methods Clin. Chem. 1953, 1, 88–97. [Google Scholar]
- Kind, P.R.N.; King, E. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J. Clin. Pathol. 1954, 7, 322. [Google Scholar] [CrossRef] [Green Version]
- Reitman, S.; Frankel, S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 1957, 28, 56–63. [Google Scholar] [CrossRef]
- Buhl, S.N.; Jackson, K.Y. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin. Chem. 1978, 24, 828–831. [Google Scholar] [CrossRef]
- Szasz, G.; Waldenström, J.; Gruber, W. Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components. Clin. Chem. 1979, 25, 446–452. [Google Scholar] [CrossRef]
- Larsen, K. Creatinine assay in the presence of protein with LKB 8600 Reaction Rate Analyser. Clin. Chim. Acta. 1972, 38, 475–476. [Google Scholar]
- Colombo, G. Determination of bilirubin with single reagent using diazotized dichloroaniline. Clin. Chem. Acta 1974, 51, 90033. [Google Scholar]
- Trinder, P. Enzymatic methods for glucose determination. Ann. Clin. Biochem. 1969, 6, 24–26. [Google Scholar] [CrossRef]
- Rossiter, P.B.; Al Hammadi, N. Living with transboundary animal diseases (TADs). Trop. Anim. Health Prod. 2009, 41, 999–1004. [Google Scholar] [CrossRef] [PubMed]
- Tuppurainen, E.S.M.; Oura, C.A.L. lumpy skin disease: An emerging threat to Europe, the Middle East and Asia. Transbound. Emerg. Dis. 2012, 59, 40–48. [Google Scholar] [CrossRef] [PubMed]
- Radostits, O.M.; Gay, C.C.; Blood, D.C.; Hinchcliff, K.W. A textbook of the diseases of cattle, sheep, pigs, goats and horses. Vet. Med. 2000, 9, 603–700. [Google Scholar]
- Agag, B.I.; Mousa, S.; Hassan, H.B.; Saber, M.S.; El-Deghidy, N.S.; El-Aziz, A.M.A. Clinical, serological and biochemical studies on lumpy skin disease. J. Appl. Anim. Res. 1992, 1, 13–23. [Google Scholar] [CrossRef]
- Hassan, H.; El-Kirdasy, A.; Ali, M.A. Immunobiochemical profile in cattle infected with lumpy skin disease. J. Basic Appl. Chem 2011, 1, 21–25. [Google Scholar]
- Scott, M.A.; Stockham, S.L. Fundamentals of Veterinary Clinical Pathology; John Wiley & Sons: Hoboken, NJ, USA, 2013; ISBN 1118686071. [Google Scholar]
- Marmor, A.T.; Klein, R.; Plich, M.; Groshar, D.; Schneeweiss, A. Elevated CK-MB isoenzyme after exercise stress test and atrial pacing in patients with ischemic heart disease. Chest 1988, 94, 1216–1220. [Google Scholar] [CrossRef]
- Abutarbush, S.M. Efficacy of vaccination against lumpy skin disease in Jordanian cattle. Vet. Rec. 2014, 175, 302. [Google Scholar] [CrossRef]
- Coles, E.H. Veterinary Clinical Pathology. 4 [grados] Ed. Vet. Clin. Pathol. 1986. [Google Scholar]
- Miller, C.L.; Madsen, J.C. IL-6 directed therapy in transplantation. Curr. Transplant. Reports 2021, 8, 191–204. [Google Scholar] [CrossRef]
- Reinhart, K.; Bauer, M.; Riedemann, N.C.; Hartog, C.S. New approaches to sepsis: Molecular diagnostics and biomarkers. Clin. Microbiol. Rev. 2012, 25, 609–634. [Google Scholar] [CrossRef] [PubMed]
- Rossi, J.-F.; Lu, Z.Y.; Massart, C.; Levon, K. Dynamic immune/inflammation precision medicine: The good and the bad inflammation in infection and cancer. Front. Immunol. 2021, 12, 595722. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, W.; Nakada, T.; Yazaki, M.; Oda, S. Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock 2016, 46, 254–260. [Google Scholar] [CrossRef] [PubMed]
- Qadis, A.Q.; Goya, S.; Yatsu, M.; Kimura, A.; Ichijo, T.; Sato, S. Immune-stimulatory effects of a bacteria-based probiotic on peripheral leukocyte subpopulations and cytokine mRNA expression levels in scouring Holstein calves. J. Vet. Med. Sci. 2014, 13–534. [Google Scholar] [CrossRef] [PubMed]
Parameters | First Sampling Time Point | Second Sampling Time Point | ||
---|---|---|---|---|
Recovered Group (n = 33) | Unrecovered Group (n = 17) | Recovered Group (n = 33) | Unrecovered Group (n = 17) | |
RBCs × 106/µL | 5.2 ± 0.0047 c | 6.6 ± 0.0076 a | 5.5 ± 0.0049 b | 6.5 ± 0.0072 a |
Hb gm% | 8.7 ± 0.0054 c | 9 ± 0.0087 b | 9.5 ± 0.0064 a | 9.1 ± 0.011 b |
PCV % | 29 ± 0.019 d | 30 ± 0.035 c | 31 ± 0.021 b | 31 ± 0.056 a |
MCV fl | 55 ± 0.063 b | 46 ± 0.081 d | 56 ± 0.068 a | 48 ± 0.11 c |
MCHC % | 30 ± 0.027 a | 30 ± 0.032 b | 30 ± 0.024 a | 29 ± 0.059 c |
Platelets × 103/µL | 130 ± 0.15 b | 100 ± 0.23 c | 140 ± 0.22 a | 83 ± 0.41 d |
TLC × 103/µL | 9.5 ± 0.021 b | 7.2 ± 0.038 c | 9.8 ± 0.025 a | 4.2 ± 0.044 d |
Neutrophil × 103/µL | 3.8 ± 0.0083 a | 3.5 ± 0.0054 b | 3.5 ± 0.009 c | 2.9 ± 0.0057 d |
Eosinophil × 103/µL | 0.15 ± 0.00033 b | 0.11 ± 0.00059 c | 0.16 ± 4 × 10−4 a | 0.067 ± 7 × 10−4 d |
Lymphocyte × 103/µL | 5.2 ± 0.011 b | 3.4 ± 0.038 c | 5.9 ± 0.015 a | 1.1 ± 0.042 d |
Monocyte × 103/µL | 0.29 ± 0.00063 a | 0.19 ± 0.001 c | 0.24 ± 0.00063 b | 0.11 ± 0.0012 d |
Parameters | First Sampling Time Point | Second Sampling Time Point | ||
---|---|---|---|---|
Recovered Group (n = 33) | Unrecovered Group (n = 17) | Recovered Group (n = 33) | Unrecovered Group (n = 17) | |
Total protein (gm/dL) | 5.5 ± 0.0026 c | 6.5 ± 0.0037 b | 6.9 ± 0.0026 a | 6.5 ± 0.0031 b |
Albumin (gm/dL) | 2.9 ± 0.0034 b | 2.7 ± 0.019 c | 3 ± 0.014 a | 2.7 ± 0.022 c |
Globulin (gm/dL) | 2.6 ± 0.004 b | 3.9 ± 0.02 a | 3.9 ± 0.015 a | 3.9 ± 0.023 a |
T. Bilirubin (mg/dL) | 0.26 ± 0.0015 d | 0.42 ± 0.0027 b | 0.29 ± 0.0015 c | 0.52 ± 0.0027 a |
D. Bilirubin (mg/dL) | 0.24 ± 0.00049 c | 0.29 ± 0.003 b | 0.23 ± 0.00049 c | 0.33 ± 0.001 a |
In. Bilirubin (mg/dL) | 0.029 ± 0.0016 d | 0.13 ± 0.0041 b | 0.05 ± 0.0015 c | 0.19 ± 0.0027 a |
AST (U/L) | 54 ± 0.17 d | 80 ± 0.72 b | 61 ± 0.11 c | 89 ± 1.4 a |
ALP (U/L) | 67 ± 0.2 d | 77 ± 0.27 b | 68 ± 0.19 c | 81 ± 0.49 a |
LDH (U/L) | 1800 ± 0.65 d | 2000 ± 0.89 b | 1800 ± 0.61 c | 2800 ± 0.83 a |
CPK (U/L) | 82 ± 0.047 d | 89 ± 0.067 c | 93 ± 0.058 b | 120 ± 0.1 a |
Glucose (mg/dL) | 62 ± 0.042 a | 50 ± 0.038 b | 44 ± 0.026 c | 43 ± 0.033 d |
Creatinine (mg/dL) | 1.2 ± 0.0015 a | 1.2 ± 0.00082 c | 1.2 ± 0.0016 b | 1.2 ± 0.00076 c |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ahmad, W.; Shabbir, M.A.B.; Ahmad, M.; Omer, M.O.; Mushtaq, R.M.Z.; Aroosa, S.; Iqbal, A.; Majeed, A. Insights into the Prognostic Role of Serum Interleukin-6 and Hematobiochemical Alterations in Cattle during Recent Outbreaks of Lumpy Skin Disease in Lodhran District, Pakistan. Vaccines 2023, 11, 113. https://doi.org/10.3390/vaccines11010113
Ahmad W, Shabbir MAB, Ahmad M, Omer MO, Mushtaq RMZ, Aroosa S, Iqbal A, Majeed A. Insights into the Prognostic Role of Serum Interleukin-6 and Hematobiochemical Alterations in Cattle during Recent Outbreaks of Lumpy Skin Disease in Lodhran District, Pakistan. Vaccines. 2023; 11(1):113. https://doi.org/10.3390/vaccines11010113
Chicago/Turabian StyleAhmad, Waqas, Muhammad Abu Bakr Shabbir, Mehmood Ahmad, Muhammad Ovais Omer, Rana Muhammad Zahid Mushtaq, Sadaf Aroosa, Asif Iqbal, and Arfa Majeed. 2023. "Insights into the Prognostic Role of Serum Interleukin-6 and Hematobiochemical Alterations in Cattle during Recent Outbreaks of Lumpy Skin Disease in Lodhran District, Pakistan" Vaccines 11, no. 1: 113. https://doi.org/10.3390/vaccines11010113
APA StyleAhmad, W., Shabbir, M. A. B., Ahmad, M., Omer, M. O., Mushtaq, R. M. Z., Aroosa, S., Iqbal, A., & Majeed, A. (2023). Insights into the Prognostic Role of Serum Interleukin-6 and Hematobiochemical Alterations in Cattle during Recent Outbreaks of Lumpy Skin Disease in Lodhran District, Pakistan. Vaccines, 11(1), 113. https://doi.org/10.3390/vaccines11010113